MID FACE VOLUME DEFICIT
Clinical trials for MID FACE VOLUME DEFICIT explained in plain language.
Never miss a new study
Get alerted when new MID FACE VOLUME DEFICIT trials appear
Sign up with your email to follow new studies for MID FACE VOLUME DEFICIT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New filler faces off against JUVÉDERM in Mid-Cheek trial
Symptom relief Recruiting nowThis study tests a new injectable gel called NOA VOLUME against the approved filler JUVÉDERM VOLUMA XC for restoring fullness in the mid-face (cheek area). About 231 adults with moderate to severe volume loss will receive one of the two fillers, with optional touch-ups. The goal …
Matched conditions: MID FACE VOLUME DEFICIT
Phase: PHASE3 • Sponsor: AbbVie • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC
-
New filler aims to restore youthful Mid-Face volume
Symptom relief Recruiting nowThis study tests a hyaluronic acid filler called Alcarisa for people with moderate to significant mid-face volume loss. Thirty adults aged 30 to 65 will receive a single injection session and be followed for 24 weeks. The goal is to see if the filler safely improves facial fullne…
Matched conditions: MID FACE VOLUME DEFICIT
Phase: NA • Sponsor: Espad Pharmed • Aim: Symptom relief
Last updated May 13, 2026 16:03 UTC